Premium
Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury
Author(s) -
Wetmore Barbara A.,
Brees Dominique J.,
Singh Reetu,
Watkins Paul B.,
Andersen Melvin E.,
Loy James,
Thomas Russell S.
Publication year - 2010
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.23574
Subject(s) - liver injury , acetaminophen , biology , messenger rna , histopathology , immunology , pharmacology , pathology , medicine , biochemistry , gene
Serum aminotransferases have been the clinical standard for evaluating liver injury for the past 50‐60 years. These tissue enzymes lack specificity, also tracking injury to other tissues. New technologies assessing tissue‐specific messenger RNA (mRNA) release into blood should provide greater specificity and permit indirect assessment of gene expression status of injured tissue. To evaluate the potential of circulating mRNAs as biomarkers of liver injury, rats were treated either with hepatotoxic doses of D‐(+)‐galactosamine (DGAL) or acetaminophen (APAP) or a myotoxic dose of bupivacaine HCl (BPVC). Plasma, serum, and liver samples were obtained from each rat. Serum alanine aminotransferase and aspartate aminotransferase were increased by all three compounds, whereas circulating liver‐specific mRNAs were only increased by the hepatotoxicants. With APAP, liver‐specific mRNAs were significantly increased in plasma at doses that had no effect on serum aminotransferases or liver histopathology. Characterization of the circulating mRNAs by sucrose density gradient centrifugation revealed that the liver‐specific mRNAs were associated with both necrotic debris and microvesicles. DGAL treatment also induced a shift in the size of plasma microvesicles, consistent with active release of microvesicles following liver injury. Finally, gene expression microarray analysis of the plasma following DGAL and APAP treatment revealed chemical‐specific profiles. Conclusion: The comparative analysis of circulating liver mRNAs with traditional serum transaminases and histopathology indicated that the circulating liver mRNAs were more specific and more sensitive biomarkers of liver injury. Further, the possibility of identifying chemical‐specific transcriptional profiles from circulating mRNAs could open a range of possibilities for identifying the etiology of drug/chemical‐induced liver injury. H EPATOLOGY 2010